The market showed a small gain Thursday, and UK 100 (CBOE) ended the day at 837 points, which is an increase of 0.1 percent. 977 shares showed a gain and 742 showed a loss. 99 shares were unchanged and closed at the same price as the previous day. There was no trading in 169 shares. Total value of the trading volume for shares and primary capital certificates Thursday was approximately 795.2 billion. | |
SOCIETE GENERALE ACCEPTANC | 90.48% |
SOCIETE GENERALE ACCEPTANC | 52.89% |
SOCIETE GENERALE ACCEPTANC | 43.97% |
Catenai Plc | 43.53% |
SOCIETE GENERALE ACCEPTANC | 43.12% |
SOCIETE GENERALE ACCEPTANC | -55.79% |
SOCIETE GENERALE ACCEPTANC | -48.78% |
SOCIETE GENERALE ACCEPTANC | -44.60% |
RWS Holdings plc | -42.68% |
SOCIETE GENERALE ACCEPTANC | -40.75% |
RELX PLC | 56104.71 |
Glencore plc | 42274.01 |
AstraZeneca | 41669.54 |
NatWest Group Plc | 29446.94 |
Barclays PLC | 24994.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.